جست‌وجوی استاد و پژوهشگر

• Imaging Biomarkers
• MRI
• PET
• +۶ مورد دیگر

David Wright is an Associate Professor (Research) in the Department of Neuroscience at Monash University, specializing in advanced neuroimaging techniques for neurological diseases. His work focuses on developing MRI-based biomarkers to study traumatic brain injury (TBI), epilepsy, and neurodegenerative disorders. He leads projects such as the NIH-funded Translational platform for epilepsy therapy and biomarker discovery and the Glymphatic System: Novel Biomarker of Disease Severity and Therapeutic Target . Affiliations: Monash Biomedical Imaging (MBI), Central Clinical School. Research Interests: Imaging biomarkers, MRI methodology, TBI pathophysiology, neuroinflammation, and neurodegenerative biomarkers. His research highlights include identifying novel MRI metrics for axonal injury in TBI and demonstrating the role of pre-existing infections (e.g., Toxoplasma gondii) in exacerbating brain damage post-TBI. He collaborates internationally on harmonizing preclinical neuroimaging data to improve translational studies. Key Projects: Translational platform for epilepsy therapy (NIH, 2022–2026) Glymphatic System Biomarkers (2022–2024) His lab, the Wright Group at Monash, focuses on imaging-driven solutions for neurological disorders, with emphasis on clinical translation. Recent work explores CD39-targeted therapies for stroke and glymphatic dysfunction in ALS.